WASHINGTON (AP) — A North Carolina drugmaker is providing its experimental antiviral drug to a Dallas patient being treated for Ebola, an emergency step authorized by the Food and Drug Administration.

Officials at Texas Health Presbyterian Hospital said Monday that their patient, Thomas Eric Duncan, is in critical condition and being treated with brincidofovir, an oral medicine developed by Chimerix Inc.

Recommended Stories

Starshield systems unlocked in Ukraine after uproar about military restrictions

If life matters, so do the midterm elections

November Social Security direct payment worth $994 goes out in six days